Navigation Links
Will 'botox' be the aspirin of the 21st century?
Date:3/18/2008

Oxford, UK 25 March 2008 The journal Medical Hypotheses (http://www.elsevier.com/locate/mehy), an Elsevier publication, has announced the winner of the 2007 David Horrobin Prize for medical theory. Written by Erle CH Lim and Raymond CS Seet of the Yong Loo Lin School of Medicine, National University of Singapore, the article, Botulinum toxin, Quo Vadis? was judged to best embody the spirit of the journal.

Botulinum toxin (botox) is a very powerful and often fatal poison produced by a rare type of food poisoning bacteria. The toxin blocks the activity of cholinergic nerves which control muscles and glands, causing glands to stop secretion and muscles to become paralysed. But in tiny doses and applied to specific structures, botox has many medical uses. Lim and Seets paper describes the early medical use of botulinum toxin in treating eye-squint, then its wider role in treating pain, excess glandular secretion and muscle spasm disorders, and its best-known use as a wrinkle remover in cosmetic surgery.

The authors go on to suggest a wide range of possible uses for botox such as calming restless legs, improving breathing in asthma, reducing sweating, and performing a chemical liposuction by removing excessive fat. In theory, botulinum toxin might be used to treat a broad range of pain syndromes, and to reduce activity for all types of glands and muscles that receive their nerve supply from the cholinergic system.

This judge for this years prize was the internationally famous neuroscientist VS Ramachandran of the University of California at San Diego, USA. Professor Ramachandran described the paper as: "A scholarly overview containing many suggestions for potentially valuable new directions of research"

The 1,000 prize was launched in 2004 and is awarded annually by Elsevier, the publisher of Medical Hypotheses. It is named in honour of Dr. David Horrobin, the renowned researcher, biotechnology expert and founder of Medical Hypotheses, who died in 2003.


'/>"/>

Contact: Ian Salusbury
ian.salusbury@elsevier.com
44-186-584-3824
Elsevier
Source:Eurekalert

Related medicine news :

1. GFX: Wrinkle-Killer or Botox(R) Hit-Man?
2. Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox
3. Clarity for Consumers on Botox Complication and Death Reports
4. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
5. Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles
6. FDA Warns of Childrens Deaths Linked to Botox
7. The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox
8. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
9. ASPS Addresses Concerns Regarding BOTOX Treatments
10. Men need more Botox than women
11. UT Southwestern urologist uses Botox to treat debilitating condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , ... December 05, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... TCS was previously a subsidiary of Chiltern International and focuses on ...
(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina Group ... New York was founded by James M. Maisel, MD and has been providing tertiary medical ... always followed a legacy of surpassing expectations amongst her peers. Growing up in a ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... "Best Surgical Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at ... , The Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together the ...
(Date:12/4/2016)... New York, NY (PRWEB) , ... December 03, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted its first Swirl: A Wine Tasting Event in New ...
(Date:12/4/2016)... ... 03, 2016 , ... Penrose Senior Care Auditors® was announced ... evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet ... for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... Dec. 5, 2016  New research by the ... Institute and the U.S. Department of Health and ... Preparedness and Response (ASPR), published online today in ... pharmacy notifications encourage patients with chronic conditions to ... The study also affirms that public-private partnerships can ...
(Date:12/5/2016)... VEGAS , Dec. 5, 2016  BD (Becton, ... leading global medical technology company, will demonstrate an enhanced ... medication management technologies, including the company,s leading Pyxis™ and ... Health-System Pharmacists (ASHP) 2016 Midyear Meeting being held ... 4-8. While national data show that approximately ...
Breaking Medicine Technology: